Stroke

Article	Citations
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association	1105
SARS-CoV-2 and Stroke in a New York Healthcare System	498
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	368
Burden of Stroke in Europe	363
Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions	247
Acute Stroke Care Is at Risk in the Era of COVID-19	196
Thrombectomy for Distal, Medium Vessel Occlusions	194
Acute Ischemic Stroke and COVID-19	193
Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke	184
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke	179
Delays in Stroke Onset to Hospital Arrival Time During COVID-19	169
Protected Code Stroke	166
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities	165
Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era	161
Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak	147
Acute Stroke in Times of the COVID-19 Pandemic	143
Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak	141
Risk and Secondary Prevention of Stroke Recurrence	136
Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19	134
Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic	129
Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke	120
Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19	119
Challenging the Ischemic Core Concept in Acute Ischemic Stroke Imaging	119
Break in the Stroke Chain of Survival due to COVID-19	119
Acute Cerebrovascular Events in Hospitalized COVID-19 Patients	116

Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China	110
Decline in Stroke Presentations During COVID-19 Surge	109
Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease	106
Cerebrovascular Complications of COVID-19	104
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke	103
Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis	101
Tenecteplase Thrombolysis for Acute Ischemic Stroke	100
Impact of Multiple Social Determinants of Health on Incident Stroke	99
Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study	94
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association	89
Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils	88
Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality	88
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams	86
Clonal Hematopoiesis Is Associated With Higher Risk of Stroke	86
Large and Small Cerebral Vessel Involvement in Severe COVID-19	85
Cancer and Embolic Stroke of Undetermined Source	85
Emergent Large Vessel Occlusion Stroke During New York City’s COVID-19 Outbreak	84
Treatment of Spontaneous Subarachnoid Hemorrhage	82
Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning	81
Trends in Stroke Incidence in High-Income Countries in the 21st Century	81
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association	80
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke	78
Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI	78
Inflammation and Stroke Risk: A New Target for Prevention	77
Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic	75
Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XI	74
Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS	74
Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China	72
Low-Frequency Oscillations Are a Biomarker of Injury and Recovery After Stroke	71
Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment	70
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment	70
Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States	68
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions	67
Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities	66
Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke	66
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin	65
The Curious Case of the Missing Strokes During the COVID-19 Pandemic	65
Intravenous Fibrinolysis for Central Retinal Artery Occlusion	65
Cilostazol for Secondary Prevention of Stroke and Cognitive Decline	65
Artificial Intelligence Applications in Stroke	63
Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Chinese Ischemic Stroke Patients	63
Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke	63
Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword	62
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis	62
Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis	62
Clot-Based Radiomics Predict a Mechanical Thrombectomy Strategy for Successful Recanalization in Acute Ischemic Stroke	61
Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia	60
Comprehensive Stroke Care and Outcomes	59
Recommendations for Regional Stroke Destination Plans in Rural, Suburban, and Urban Communities From the Prehospital Stroke System of Care Consensus Conference: A Consensus Statement From the American	59
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease	59

Distinct Commensal Bacterial Signature in the Gut Is Associated With Acute and Long-Term Protection From Ischemic Stroke	58
Analysis of Nationwide Stroke Patient Care in Times of COVID-19 Pandemic in Germany	58
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study	57
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events	57
Mechanical Thrombectomy in Basilar Artery Occlusion	56
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19	56
Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views	56
Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic	55
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial	55
Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset	54
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial	54
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy	54
Endovascular Thrombectomy for Acute Ischemic Strokes	54
Ischemic Stroke Epidemiology During the COVID-19 Pandemic	53
Acute Neurological Deterioration in Large Vessel Occlusions and Mild Symptoms Managed Medically	52
Pervasive White Matter Fiber Degeneration in Ischemic Stroke	52
Dynamic Regional Brain Atrophy Rates in the First Year After Ischemic Stroke	52
Acute Cerebrovascular Events With COVID-19 Infection	52
Chronic Kidney Disease and Cerebrovascular Disease	52
Qualitative and Quantitative Wall Enhancement on Magnetic Resonance Imaging Is Associated With Symptoms of Unruptured Intracranial Aneurysms	51
Stroke Etiology and Thrombus Computed Tomography Characteristics in Patients With Acute Ischemic Stroke	51
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes	51
Good Clinical Outcome Decreases With Number of Retrieval Attempts in Stroke Thrombectomy	50
Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion	49
Endothelial Dysfunction in the Brain	49
Mismatch Profile Influences Outcome After Mechanical Thrombectomy	49
Incidence and Mortality of Cerebral Venous Thrombosis in a Norwegian Population	49
Higher Doses Improve Walking Recovery During Stroke Inpatient Rehabilitation	49
Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke	48
Deep Learning–Derived High-Level Neuroimaging Features Predict Clinical Outcomes for Large Vessel Occlusion	48
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows	48
Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage	48
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use	48
PERK (Protein Kinase RNA-Like ER Kinase) Branch of the Unfolded Protein Response Confers Neuroprotection in Ischemic Stroke by Suppressing Protein Synthesis	48
2B, 2C, or 3	47
Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke	47
Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction–Mediated Cell-Cell Interaction	47
SARS-CoV-2 and Stroke Characteristics	46
Deep Learning Based Software to Identify Large Vessel Occlusion on Noncontrast Computed Tomography	46
Stroke Incidence by Sex Across the Lifespan	46
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms	45
Computed Tomography Perfusion After Thrombectomy	45
CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage	45
Favorable Venous Outflow Profiles Correlate With Favorable Tissue-Level Collaterals and Clinical Outcome	45
Stroke Prognostic Scores and Data-Driven Prediction of Clinical Outcomes After Acute Ischemic Stroke	45
Immunodepression, Infections, and Functional Outcome in Ischemic Stroke	45
Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack	45
Endovascular Therapy of Anterior Circulation Tandem Occlusions	44
A Nomogram for Predicting Stroke Recurrence Among Young Adults	44
Poststroke Cognitive Impairment Negatively Impacts Activity and Participation Outcomes	44
Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke	44
Impact of Antiplatelet Therapy During Endovascular Therapy for Tandem Occlusions	44
Incidence of Acute Ischemic Stroke With Visible Arterial Occlusion	43
Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Fa	43
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review–Based, Individual Participant Data Network Meta-Analysis	43
Placental Mitochondria Therapy for Cerebral Ischemia-Reperfusion Injury in Mice	43
Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion	43
Predicting Infarct Core From Computed Tomography Perfusion in Acute Ischemia With Machine Learning: Lessons From the ISLES Challenge	43
Cerebroprotection for Acute Ischemic Stroke: Looking Ahead	43
High Admission Glucose Is Associated With Poor Outcome After Endovascular Treatment for Ischemic Stroke	43
Prevalence of Ipsilateral Nonstenotic Carotid Plaques on Computed Tomography Angiography in Embolic Stroke of Undetermined Source	42
Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States	42
Microvascular Dysfunction in Blood-Brain Barrier Disruption and Hypoperfusion Within the Infarct Posttreatment Are Associated With Cerebral Edema	42
Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset	42
Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke	42
Effect of COVID-19 on Emergent Stroke Care	42
Predictors of Poststroke Aphasia Recovery	42
Young Women Had More Strokes Than Young Men in a Large, United States Claims Sample	42
Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study	42
Collateral Circulation in Thrombectomy for Stroke After 6 to 24 Hours in the DAWN Trial	41
Qualitative Study of Chinese Stroke Caregivers’ Caregiving Experience During the COVID-19 Pandemic	41
Twenty-Year Time Trends in Long-Term Case-Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology	41
Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials	41
Mechanical Thrombectomy in Patients With Ischemic Stroke With Prestroke Disability	41
Sleep Duration and Stroke	41
Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation	41
Female Stroke	41
Contrast-Induced Encephalopathy After Endovascular Thrombectomy for Acute Ischemic Stroke	41
Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke	40
Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm	40

Clinical and Imaging Determinants of Collateral Status in Patients With Acute Ischemic Stroke in MR CLEAN Trial and Registry	40
Acute Ischemic Stroke in Patients With COVID-19	40
Stroke Acute Management and Outcomes During the COVID-19 Outbreak	40
Mobile Stroke Unit Computed Tomography Angiography Substantially Shortens Door-to-Puncture Time	40
New Insights Into Cerebrovascular Pathophysiology and Hypertension	40
Acute Stroke Management During the COVID-19 Pandemic	40
Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke	40
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection	40
Risk of Paradoxical Embolism (RoPE)–Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure	40
Increased Wall Enhancement During Follow-Up as a Predictor of Subsequent Aneurysmal Growth	39
Stroke Care in the United Kingdom During the COVID-19 Pandemic	39
Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage	39
Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke	39
General Anesthesia Versus Conscious Sedation and Local Anesthesia During Thrombectomy for Acute Ischemic Stroke	39
Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage	39
Recommendations for Clinical Trials in ICH	39
Circadian Biology and Stroke	39
Ischemic Core Overestimation on Computed Tomography Perfusion	39
Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients	39
Association Between the Onset Pattern of Adult Moyamoya Disease and Risk Factors for Stroke	39
Advancing Stroke Recovery Through Improved Articulation of Nonpharmacological Intervention Dose	39
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation	39
Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown	39
Thrombectomy Versus Combined Thrombolysis and Thrombectomy in Patients With Acute Stroke	39
Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke	38
Endovascular Therapy for Stroke due to Basilar Artery Occlusion	38
Long-Term Cognitive Decline After Stroke: An Individual Participant Data Meta-Analysis	38
Under-Enrollment of Women in Stroke Clinical Trials	38
Mechanical Thrombectomy in Medium Vessel Occlusions	38
Embolic Stroke of Undetermined Source and Symptomatic Nonstenotic Carotid Disease	38
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage	38
Adiposity and Outcome After Ischemic Stroke	37
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia	37
Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia	37
Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association	37
Lipid-Lowering Therapy and Hemorrhagic Stroke Risk	37
Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?	37
Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion	37
Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease	37
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association	36
Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial	36
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke	36
Neuroinflammation, Stem Cells, and Stroke	36
Switching to Tenecteplase for Stroke Thrombolysis	36
Sex Differences in Presentation of Stroke: A Systematic Review and Meta-Analysis	36
Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke	36
Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth	35
Posterior National Institutes of Health Stroke Scale Improves Prognostic Accuracy in Posterior Circulation Stroke	35
Prediction of Independent Walking in People Who Are Nonambulatory Early After Stroke	35
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Trans	35
Predicting Longitudinal Progression in Functional Mobility After Stroke	34
Modifiable Risk Factors Associated With Moyamoya Disease	34
Quantitative Histogram Analysis on Intracranial Atherosclerotic Plaques	34
Depression, Anxiety, and Suicide After Stroke: A Narrative Review of the Best Available Evidence	34
Direct Transfer to Angio-Suite Versus Computed Tomography–Transit in Patients Receiving Mechanical Thrombectomy	34
The Story of Intracerebral Hemorrhage	34
Predictors of Unexplained Early Neurological Deterioration After Endovascular Treatment for Acute Ischemic Stroke	34
Studying Stroke Thrombus Composition After Thrombectomy: What Can We Learn?	34
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke	34
Atrial Fibrillation Following Patent Foramen Ovale Closure	34
Adherence to the EAT-Lancet Diet and Risk of Stroke and Stroke Subtypes: A Cohort Study	34
Detection and Quantification of Symptomatic Atherosclerotic Plaques With High-Resolution Imaging in Cryptogenic Stroke	33
Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy	33
Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis	33
Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy	33
Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke	33
Aβ (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts	33
Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke	33
Determinants of the Presence and Size of Intracranial Aneurysms in the General Population	33
The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis	32
Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation	32
Effects of Collateral Status on Infarct Distribution Following Endovascular Therapy in Large Vessel Occlusion Stroke	32
Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS Registry	32
Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke	32
Genetics of Intracranial Aneurysms	32
Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association	32
Plaque Distribution Correlates With Morphology of Lenticulostriate Arteries in Single Subcortical Infarctions	32
Alteplase for Acute Ischemic Stroke in Patients Aged >80 Years	32
Clinical Course and Mortality of Stroke Patients With Coronavirus Disease 2019 in Wuhan, China	32
Reperfusion Therapy Frequency and Outcomes in Mild Ischemic Stroke in the United States	32
Number of Retrieval Attempts Rather Than Procedure Time Is Associated With Risk of Symptomatic Intracranial Hemorrhage	32
Access to Mechanical Thrombectomy for Ischemic Stroke in the United States	32
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome	32
Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease	32
Safety and Outcome of Carotid Dissection Stenting During the Treatment of Tandem Occlusions	31
Efficacy and Safety of Recanalization Therapy for Acute Ischemic Stroke With Large Vessel Occlusion	31
Sirtuin 5-Mediated Lysine Desuccinylation Protects Mitochondrial Metabolism Following Subarachnoid Hemorrhage in Mice	31
Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly	31
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke	31
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030	31
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo	31
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6	31
Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation	31
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials	31
Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source	30